Add Yahoo as a preferred source to see more of our stories on Google. Most people who've had a heart attack—or who fear having one—focus on surviving the cardiovascular event itself. But what happens ...

Cardiogenic shock is characterized by depression of cardiac function that leads to low blood pressure, coronary ischemia, and further decreased cardiac contractility resulting in tissue hypoxemia. The ...

WASHINGTON, DC—Early-stage cardiogenic shock leads to poor outcomes but is underrecognized, with only one in four affected patients having any indication in their electronic medical record (EMR) that ...

TAMPA (BLOOM) – Dr. Debbie Rinde-Hoffman joined Bloom’s Tampa Bay Heart Walk special to share the symptoms and to educate people about Cardiogenic Shock. “It’s a potentially lethal complication of ...

Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in north ...

Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement is safe and effective in people with aortic stenosis and cardiogenic ...

Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. In this multicenter trial, ...

Washington, D.C. – MAY 1, 2025 – In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% ...

Physicians forced to make rapid-fire choices, with limited evidence, in acute myocardial infarction complicated by cardiogenic shock (AMICS) finally have what they’ve long been waiting for: positive ...

IV iron supplementation in HFrEF patients showed a 21% reduction in cardiovascular death or first HF hospitalization, despite not meeting primary endpoints. Intra-aortic balloon pump did not ...